| Literature DB >> 28294077 |
Jennifer L Goldman1, Rachael K Ross2, Brian R Lee1, Jason G Newland3, Adam L Hersh4, Matthew P Kronman5, Jeffrey S Gerber2.
Abstract
We analyzed antifungal and antiviral prescribing among high-risk children across freestanding children's hospitals. Antifungal and antiviral days of therapy varied across hospitals. Benchmarking antifungal and antiviral use and developing antimicrobial stewardship strategies to optimize use of these high cost agents is needed. Infect Control Hosp Epidemiol 2017;38:743-746.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28294077 PMCID: PMC6697168 DOI: 10.1017/ice.2017.40
Source DB: PubMed Journal: Infect Control Hosp Epidemiol ISSN: 0899-823X Impact factor: 3.254